Novo Nordisk’s insulin brand Mixtard will continue to be available in vials, the Danish healthcare company clarified, even as it phases out its penfill. The penfill is being phased out as part ...

Novo Nordisk will continue offering its top-selling insulin brand, Mixtard, in vial form in India, despite phasing out Penfill cartridges. This decision follows concerns about the discontinuation ...

However Mixtard in India will continue to be available in vials. Along with it, other form of insulin including human insulin from Novo Nordisk will continue to be available in vials & devices for ...

After just 48 hours of drug exposure, the cells began producing insulin and responding to glucose—just like normal beta cells do. Related Stories Common diabetes drugs may protect against ...

A recent study found that the homeostasis model assessment insulin resistance (HOMA-IR), quantitative insulin-sensitivity check index (QUICKI), and fasting glucose/insulin ratio (FGIR) were ...

When working properly, your pancreas releases insulin to help cells absorb glucose from your bloodstream. Without enough insulin or when cells don’t respond to it properly, blood sugar levels ...

Medtronic is seeking regulatory clearance for an insulin pump that could expand its partnership with Abbott. In its application to the Food and Drug Administration, Medtronic is seeking clearance ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. A controversial lawsuit brought by the U.S. Federal Trade ...

‘Scientists have discovered the crucial role of the hnRNP A1 molecule in maintaining #myelin sheath integrity. Could this be a new avenue for understanding #schizophrenia? #Neuroscience # ...